Caribou Biosciences
Presence
Caribou Biosciences is one of the...
Caribou Biosciences is a company listed under the stock ticker CRBU (US).
Executives
View the org chart displaying its 26 main executives
Most searched biographies at Caribou Biosciences
- Rachel Haurwitz, Director, President and Chief Executive Officer
- Ran Zheng, Director
- Nancy Whiting, Director
Popular executive movements at Caribou Biosciences
- Tim Kelly has joined the company as Chief Technology Officer (posted on January 8 2024).
- Reigin Zawadzki has joined the company as Chief People Officer (posted on September 27 2023).
Create your alert
to follow the executive moves at Caribou Biosciences.
Biotechnology
Caribou Biosciences has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Caribou Biosciences
- Caribou Biosciences Reports Positive Additional Data from CB-010 Allogeneic CAR-T Cell Therapy Phase 1 ANTLER Trial at the European Hematology Association (EHA) 2022 Hybrid Congress | Caribou Biosciences, Inc.
- Caribou Biosciences Announces Webcast Conference Call to Highlight Initial CB-010 ANTLER Phase 1 Data Presentation at EHA on June 10, 2022 | Caribou Biosciences, Inc.
- Caribou Biosciences Presents Data on Mechanism Underlying Superior Specificity of Caribou’s chRDNA Genome-Editing Technology in Primary Human T cells | Caribou Biosciences, Inc.
- Caribou Biosciences Announces Positive Initial Data for CB-010 Anti-CD19 Allogeneic CAR-T Cell Therapy | Caribou Biosciences, Inc.
- Caribou Biosciences Announces Appointment of David Johnson to its Board of Directors | Caribou Biosciences, Inc.
- Caribou Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updates | Caribou Biosciences, Inc.
- Caribou Biosciences to Present at Upcoming Investor Conference | Caribou Biosciences, Inc.
- Caribou Biosciences Announces Presentation of chRDNA Platform Data at the 25th Annual Meeting of the American Society for Gene and Cell Therapy (ASGCT) | Caribou Biosciences, Inc.
- Caribou Biosciences to Share CB-010 Initial Clinical Data at the Upcoming European Hematology Association (EHA) 2022 Hybrid Congress | Caribou Biosciences, Inc.
- Caribou Biosciences Presents Positive Preclinical Data for Allogeneic Anti-BCMA CAR-T Cell Therapy Candidate CB-011 at the American Association for Cancer Research (AACR) Annual Meeting | Caribou Biosciences, Inc.
- View more press releases Close
Social media about Caribou Biosciences
- Caribou Biosciences on Wikipedia, Google News & Yahoo Finance
- Caribou Biosciences on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Scott Braunstein 
Call Caribou Biosciences at +1 510...
